Cargando…
Low levels of serum IL‐39 are associated with autoimmune thyroid disease
BACKGROUND: Interleukin (IL)‐39 is a novel member of IL‐12 cytokine family, but its role in autoimmune thyroid diseases (AITD) is unclear. The aim of the present study was to determine serum levels of IL‐39 in Hashimoto's thyroiditis (HT) and Graves' disease (GD) patients. METHODS: A total...
Autores principales: | Weng, Linjie, Huang, Guoqing, Gong, Luping, Xu, Jialu, Mao, Yushan, Li, Yan, Li, Mingcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993603/ https://www.ncbi.nlm.nih.gov/pubmed/35182078 http://dx.doi.org/10.1002/jcla.24284 |
Ejemplares similares
-
Low serum interleukin‐38 levels in patients with Graves’ disease and Hashimoto’s thyroiditis
por: Xu, Jialu, et al.
Publicado: (2021) -
Decreased serum interleukin‐41/Metrnl levels in patients with Graves' disease
por: Gong, Luping, et al.
Publicado: (2022) -
Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
por: Huang, Guoqing, et al.
Publicado: (2022) -
Serum IL‐36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation
por: Li, Yan, et al.
Publicado: (2020) -
Interleukin 39: a new member of interleukin 12 family
por: LU, ZHIYU, et al.
Publicado: (2020)